Temporal Response of Arterial Stiff ness to Ultra-Marathon
itself may lead to an acute increase in systemic arterial stiff ness [ 4 ] and it is possible that this may relate to more enduring arterial changes. At present, the time-course of vascular changes during a race and into recovery has not been examined, but a more in-depth understanding is crucial for interpreting the consequences of these eff ects. The primary purpose of the present investigation was to evaluate the temporal changes in arterial stiff ness of a group of ultramarathon runners during and following participation in a 75 km trail-running race. We hypothesized that arterial stiff ness would be increased as a result of competitive ultra-marathon participation, but that these changes would resolve quickly during recovery.
Methods

Introduction
▼
Participation rates in endurance and ultra-endurance running events have increased dramatically in recent years [ 14 ] , leading to unprecedented numbers of athletes training for and racing at distances up to and exceeding the typical marathon. The demographic composition of participants is also changing from the young, elite athlete to incorporate greater numbers of older and subelite competitors [ 15 ] . Arterial stiff ness is known to be associated with an increased risk of cardiovascular and all-cause mortality [ 29 ] . It is well established that habitual participation in regular aerobic physical activity is associated with lower levels of arterial stiff ness at rest and an attenuation of the progressive stiff ening of arteries with age [ 27 ] . Research has also demonstrated a chronically increased resting arterial stiff ness in some competitive endurance athletes [ 30 ] when compared with recreationally active controls; yet this area remains controversial, results are mixed [ 23 ] and underlying mechanisms of this eff ect are unclear. Our laboratory has presented evidence that participation in an ultra-marathon
The purpose of this investigation was to characterize the arterial stiff ness of male ultra-marathon runners (n = 9) using pulse wave velocity (cfPWV) and radial tonometry over the course of an ultra-marathon and during recovery. Measures were collected at rest, immediately following 45 km/75 km of running, then following 60 and 90 min of recovery. No statistical diff erence was found between baseline cfPWV and normative values. The cfPWV of ultra-endurance runners decreased at 45 km (3.4 ± 1.6 m/s, p = 0.006), followed by an increase (1.6 ± 1.8 m/s, p = 0.04) toward baseline levels at the 75 km mark. Radial tonometry measures also indicated small artery stiff ness was transiently increased after 75 km. The amount of training time (r = 0.82, p = 0.007) and the duration of a typical training session (r = 0.73, p = 0.03) were correlated strongly with persisting decrements in large artery compliance at 60 min of recovery. The fi nding that arterial stiff ness decreased at the 45 km distance and then reverted back toward baseline levels with prolonged running, may indicate a role of exercise duration or accumulated stress for aff ecting vascular compliance. At present, it is premature to suggest that athletes should alter training or racing practices to protect vascular health.
condition, which was verifi ed using the PAR-Q + screening questionnaire [ 32 ] . All participants provided written informed consent in accordance with guidelines of the Clinical Research Ethics Review Board at the University of British Columbia that approved this study. This study also meets the ethical standards of this journal [ 10 ] . To examine the eff ects of a chronic ultra-endurance training stimulus on changes in arterial stiff ness, we used a case control design and required all participants to report training practices such as running frequency and weekly mileage. Resting arterial stiff ness was measured at baseline using both carotid-femoral pulse wave velocity (cfPWV) and radial applanation tonometry (AT) (CR-2000, Hypertension Diagnostics, Eagan, Minnesota), 3 days prior to competition. Participants were instructed to refrain from strenuous exercise, smoking, and caff eine for ≥ 24 h prior to laboratory measures. Maximal aerobic power (VO 2 max) was measured in the laboratory following baseline vascular measures using a graded exercise test on a mechanically driven treadmill with gas analysis. Breath-by-breath expired gas and ventilatory parameters were acquired and averaged every 15 s using a calibrated metabolic cart (Ergocard; Medisoft, Dinant, Belgium). Rating of perceived exertion (RPE) and heart rate (S610i; Polar Electro, Oy, Finland) were recorded within the last 15 s of each stage. The staged test began with a 3 min warm-up using 5 mph-0 % grade after which the fi rst 2 min stage was introduced using 6 mph-0 % grade. Each successive 2 min stage increased 1 mph and 2 % grade until test termination. Termination criteria included: a failure of oxygen consumption to increase at least 150 mL · min − 1 with an increase in workload or participant volitional fatigue with a RPE greater than 17 on the Borg 6-20 scale. The test took an average of 11 ± 1 min to complete. We employed a repeated measures experimental design to examine the temporal eff ects of prolonged running participation on human vasculature. Vascular stiff ness measures were repeated on each runner throughout participation in an ultramarathon trail running foot race after 45 km (mid-race approximating marathon distance), following the completion of 75 km, 60 min post-fi nish, and 90 min post-fi nish. At each measurement, AT and cfPWV measures were recorded simultaneously following a 10 min period of supine rest.
Pulse wave velocity
Pulse waves were collected at the carotid and femoral artery for analysis of cfPWV using infrared photoelectric sensors and recorded on LabChart software (Version 5.5.6. ADInstruments, Colorado Springs, CO) via signal processing through an ADI Powerlab. A single investigator screened all recordings and selected a minimum of 30 consecutive cardiac cycles, which were averaged to calculate the pulse transit time from foot-to-foot of consecutive waves. The foot of the wave was auto-detected using a specifi cally designed software macro to recognize and mark the last point before the upstroke. The distance between measurement points on the carotid and femoral arteries was measured as the shortest distance (to the nearest 0.5 cm) above the body using a standard anthropometric tape. For comparison of baseline measures with published norms, cfPWV measures were corrected using a scaling factor of 0.8 according to the method outlined by Sugawara et al. [ 26 ] , and as was employed for the publication of large scale normative cfPWV data used for comparison [ 21 ] .
Applanation tonometry
Applanation tonometry measures were collected using the radial artery of the right wrist with an automated sphygmomanometer affi xed to the upper left arm for brachial pressure calibration. Prior to collection, the participant's wrist was stabilized and the signal strength maximized according to manufacturer instructions [ 11 ] . The CR-2000 uses a modifi ed 2 element Windkessel model which allows both large artery (C 1 ) and small artery (C 2 ) compliance estimations to characterize the capacitive vessels such as the aorta and small oscillatory vessels associated with microvascular circulation, respectively. Combined with anthropometric participant data for the calculation of body size, pulse contour data is used to auto-calculate additional cardiovascular indices including heart rate, blood pressure, pulse pressure, cardiac output, and systemic vascular resistance. The theoretical basis for the method of systemic arterial compliance using the area under the diastolic pulse wave has been described in detail [ 20 ] and strong agreement between measures has been reported for invasively determined direct measures [ 6 ] as well as intima media thickness [ 20 ] and MRI derived measures of aortic distensibility and endothelial function [ 25 , 33 ] . As opposed to cfPWV, which specifi cally considers the descending aortic segment, it is postulated that C 1 and C 2 measures off er a more inclusive estimation of the stiff ness of the systemic large and small arteries respectively. The ultra-marathon race was specifi cally scheduled for the purposes of this investigation, and took place on the forested trails surrounding the campus of the University of British Columbia. Participants were encouraged toward realistic competitive performance through use of a representative race format as opposed to prolonged individual treadmill running. This format also permitted race tactics, pacing, and hydration/fuelling to occur as they naturally would in ultra-marathon trail running races. The course was typical of an ultra-marathon trail running course, with various undulations in terrain, winding turns, natural and man-made obstacles (i. e., boardwalks), and one major climb each lap (140 m vertical). Participants were directed to complete 5 laps of a 15.1 km course, with each lap starting and fi nishing at the laboratory. On race day, the weather was clear and sunny with a barometric pressure of 749.3 mmHg, 35 % humidity at race start (7 am) and temperatures varying from 20.1-26.8 °C throughout the day. Aid stations with food and drink were placed approximately every 3 km throughout the course, allowing collection of subjective (RPE) and objective (heart rate, from coded wrist watch) physiological data 5 times per lap. Following the third lap (45 km), or at a distance approximating the standard marathon (42.2 km), participants had a mandatory break during which vascular measures were repeated.
Statistical analysis
Baseline arterial stiff ness was compared with an age-weighted population mean value using a one sample t-test. Temporal changes in cfPWV, applanation tonometry, and related cardiovascular measures were examined using repeated measures ANOVA with simple and repeated contrasts to compare individual stages to baseline and between consecutive stages, respectively. To control for the potential infl uence of changes in blood pressure, cfPWV measures were examined with and without a correction for mean arterial pressure (cfPWV/MAP), which was calculated using the blood pressure measured simultaneous to cfPWV with the integrated sphygmomanometer of the applanation tonometer. Relationships between participant characteristics, including training practices, and changes in arterial stiff ness from baseline were examined using Pearson correlation. Analyses were performed using SPSS software (version 20.0; SPSS, Inc., Chicago, IL). Signifi cance was set a priori at p < 0.05 and results are reported as mean ± SD.
Results
▼
Descriptive participant characteristics of the competitive ultramarathon group are presented in • ▶ Table 1 . All athletes completed the full ultra-marathon distance, with the exception of 2 participants who withdrew prior to the fi nal lap (60 of the 75 km). Follow-up measures were completed on both athletes who stopped after lap 4, as they had still completed an "ultramarathon" distance (i. e., ≥ 50 km), albeit shorter than the intended 75 km race distance. A comparison of the results including and excluding the 2 drop-outs revealed no signifi cant eff ect on vascular measures at exercise cessation or on recovery measures; thus data for these subjects was included in the fi nal analysis. The time between exercise cessation and vascular measures, was 29.7 ± 6.3 min at mid-race, 27.2 ± 10.6 min at race fi nish, 65.2 ± 7.7 min at the 1-h recovery point and 97.9 ± 3.9 min at the 1.5-h recovery follow-up.
Pulse wave velocity
Comparison of baseline cfPWV measures with published normative data [ 21 ] from a large population study (n = 1 455) revealed that 78 % of our participants had resting cfPWV values above the normative mean, and 44 % had values above the 90 th percentile. A one sample t-test against the estimated ageweighted normative mean was not statistically signifi cant. Table 2 . Heart rate showed an expected increase from baseline during the race, which later decreased during recovery but was still elevated above resting levels. Estimated cardiac output was similarly increased the 45 km and 75 km marks, but returned to baseline levels during recovery. Systemic vascular resistance decreased immediately post exercise, followed by a return to baseline levels in recovery.
Discussion
▼
The major novel fi nding of the present investigation was that the cfPWV of ultra-marathon runners decreased after running the distance of a marathon (45 km), but this decrease in arterial stiff ness below baseline levels began to revert by the completion of 75 km. The magnitude of this returning arterial tone that occurred between 45 km and 75 km was substantial (1.6 m/s) and of a magnitude that would be considered to be of clinical importance at rest. 
Pulse wave velocity Baseline values
Compared with normative population data, we noted that ultrarunners tended to have cfPWV values that were consistently (7/9) above their expected age group values, with just under half of these runners falling above the 90 th percentile for their age group. This purely observational fi nding corroborates previous research concerning marathon runners, in which a higher cfPWV was found compared with recreationally active controls and was attributed to the high intensity of habitual marathon training and racing [ 30 ] . Alterations in baseline arterial stiff ness of runners may also result from training adaptations, which could benefi t performance, but have aff ects that endure beyond exercise and become pathophysiological during rest. In particular, it has been suggested that an augmented stroke volume resulting from training induced hypervolemia and bradycardia may contribute to increases in vascular load and an eventual fatigue and fragmentation of vascular elastin fi bres [ 12 , 30 ] . This resting vascular load may be further amplifi ed by alterations in central pulse pressure and the arrival of refl ected pressure waves during a prolonged systolic period [ 12 ] . Related adaptations in cardiac elastance and training/racing induced infl ammation may also play a causative role for the habitual runner [ 31 ] . Notably, we did not reveal statistical signifi cance between our overall group mean and normative data using a one-sample t test; however, we cautiously interpret this fi nding as our sample was relatively small and this statistical method required comparison with a normative mean created by averaging the means across age groups. Consideration of each runner's PWV value within his own age-category may be of greater validity considering the known eff ect of age on cfPWV. The observation that the majority of runners were in the high end of their age category for cfPWV is noteworthy given the departure from the expected values, which makes this fi nding of potential clinical (if not statistical) signifi cance. Elevated central PWV is a strong predictor of future cardiovascular events and all-cause mortality, such that an increase in PWV by 1 m/s is associated with a 15 % increase in risk [ 29 ] . Thus, ultra-marathoners in the present study whose values closely approximated this magnitude of increase from age-matched norms (1 ± 1.7 m/s above the mean or 0.7 ± 1.7 m/s above the median) would be expected to have a 12-15 % increase in cardiovascular risk. However, given the depth and breadth of evidence that endurance exercise is associated with a decreased risk of cardiovascular morbidity and mortality [ 9 , 19 , 28 ] , the long-term implications for this particular group are unclear and deserving of further investigation.
PWV following prolonged exercise
Vlachopoulos et al. [ 30 ] examined changes in cfPWV following a marathon race and reported no change in cfPWV whereas we showed a reduction in arterial stiff ness at the 45km mark, which approximated this same distance. Given previous research demonstrating that particularly high intensity exercise results in notable arterial stiff ening [ 24 ] , it is probable that the observed Table 2 Cardiovascular indices of male ultra-marathon runners calculated using radial applanation tonometry, before, during, and after participation in an ultra-endurance marathon race. 50.7 ± 5.5 53 ± 6.2 51.5 ± 6.5 46.9 ± 7.2 49.9 ± 9.9 rate (beat/min) 52 ± 5 78 ± 8* aff ects at a race distance approximating the marathon are intensity dependent. During a discrete competitive 42.2 km marathon, the typical intensity is extremely vigorous; however, in the current investigation as part of a longer ultra-marathon race, the intensity of the fi rst 45 km was lower, owing to necessary pacing strategies of the competitors. Davies and Thompson [ 7 ] have shown that accomplished runners who can maintain 82 ± 3 % of VO 2 max during a marathon were capable of sustaining only 67 ± 6 % of VO 2 max during an ultra-marathon of ~85 km. In line with this observation, we note that our athletes raced at 68 % VO 2 max, and this form of moderate intensity physical activity has repeatedly been shown to be associated with decreases in arterial stiff ness post-exercise and at rest with moderate duration bouts [ 13 , 17 , 22 ] . The discrepancy between increased baseline arterial stiff ness and acutely decreased arterial stiff ness following moderate intensity exercise may, amongst other causes, be related to the increase in heart rate associated with the exercise itself [ 12 ] . During and immediately after exercise an elevated HR would serve to avoid the simultaneous arrival of the systolic and refl ected pressure waves in opposition to the eff ect that a bradycardic training adaptation has for augmenting systolic pressure waves at rest. In the absence of extreme intensity or distance it is also likely that there is an adequate bioavailability of vasoactive substances (which are mediated by factors such as shear stress and infl ammation) to sustain appropriate vasodilation and reductions in peripheral vascular resistance [ 8 , 31 ] , which would serve to reduce the propagation of pressure waves. Given evidence that repeated bouts of high intensity exercise increase arterial stiff ness in a stepwise manner [ 24 ] and past evidence of systemic arterial stiff ening with more prolonged exercise exposures [ 4 ] , we propose that particularly long duration exercise may have the same eventual eff ect in the absence of high intensity. This is supported to some extent by our fi nding that cfPWV did not remain at a state of decreased stiff ness (demonstrated at the 45 km mark) despite an unchanging exercise intensity. Given evidence of arterial stiff ening following a more prolonged race [ 4 ] , it seems possible that arterial stiff ness may have continued past baseline values had the ultra-marathon been of a greater duration. Compelling experimental evidence shows that induced systemic infl ammation directly contributes to arterial stiff ening [ 31 ] , and it is well documented that ultramarathon is associated with increased infl ammatory response [ 16 ] , potentially off ering another mechanistic explanation to sub-acute and more chronic stiff ening. We postulate that the high-volume exposures of exercise and the associated infl ammatory response may thus have residual baseline eff ects, explaining the above average cfPWV at baseline. In support of this theory, infl ammatory responses following an off -road running race have been shown to be strongly correlated with baseline levels, such that runners who revealed the greatest increases in infl ammation post-race were also the individuals with the highest levels at rest [ 1 ] .
Applanation tonometry AT following prolonged exercise
In contrast to previous fi ndings regarding the eff ects of ultramarathon racing by our group [ 4 ] , we observed only an increase in C 2 (small arteries), but not C 1 stiff ness (large arteries) in the current investigation. The increase in C 2 is most likely attributable to changes in the peripheral vasculature at the local working muscles and supports previous fi ndings of diff erential body segment eff ects of exercise [ 8 , 23 ] ; however, the lack of an eff ect on C 1 diff ers from previous ultra-marathon fi ndings [ 4 ] . The major diff erence between investigations was the volume of exercise exposure, which suggests the possible existence of a doseresponse (or a threshold) eff ect. In our original investigation, participants ran through mountainous terrain for distances of 120-195 km, which required between 20-40 consecutive hours to complete [ 4 ] ; whereas in the present investigation, the ultramarathon was on less physically challenging terrain, averaged about 50 % of the distance, and only required 11 ± 3 h (range 8.5-13.8 h). Given evidence that infl ammatory responses and associated arterial stiff ening can occur one or more days post exposure [ 1 , 3 ] , it is possible that these responses would have presented in participants of the longer distance race, but not in the shorter ultra-marathon (or marathon distance) used in the present investigation. Systemic arterial compliance changes may also have occurred past the 90 min post-race recovery measure, but this cannot be confi rmed. Despite this null fi nding, this data off ers preliminary insight into the conditions likely associated with changes in arterial function and the role of exercise duration. Future investigations should include measures of infl ammation and a longer post-race follow-up period. Lastly, we observed strong relationships between training variables and outcomes such that participants who trained less (both in terms of session time and total weekly exercise), had greater C 1 stiff ness at the 1-h mark of recovery, and participants who trained at a lower exercise intensity (RPE) had greater amounts of C 2 stiff ening at the 45 km mark. This could be interpreted to suggest that lower training volumes left some competitors less prepared to deal with the vascular stress imposed by this type of exercise, which was refl ected in a relative large artery stiff ening at 1 h of recovery. Similarly, those who trained with less intensity may have revealed greater stiff ening of the peripheral vasculature (C 2 ) owing to local metabolite changes and exhaustion of endothelial function mediators [ 8 ] , which did not occur to the same extent in more fi t participants who were adapted to higher training stresses. This is supported by the fact that VO 2 max was also strongly associated with changes in C 2 stiff ness at the 45 km point, such that the more fi t participants revealed smaller changes from baseline, but remains speculative. Although group mean data did not vary from baseline at these time points, these associations explain the relationships that exist within the individual variability. It is thus possible that fi tness was a further contributory factor to the inter-individual variability, which is consistent with infl ammatory exercise responses [ 2 , 5 ] , and specifi c investigation into the impact of fi tness on vascular response during ultra-endurance exercise is needed.
In the present investigation diff erences were found between measures of aortic stiff ness (cfPWV) and arterial compliance (AT), which are the theoretical inverse of one another. However, it is important to note that despite their similarities (i. e., the descending aorta is indeed a large capacitance artery) these measures diff er substantially and both off er strengths and limitations which have been reviewed previously [ 18 ] . One major diff erence is that stiff ness is determined by wave velocity as measured across a discrete distance, whereas compliance is estimated across regions of the body from a single point on the distal radial artery using a transfer function. Aside from diff ering methods of computation, these measures also detect the properties of diff erent segments of the body; wherein cfPWV is specifi c to the properties of the descending aorta alone and C 1 off ers a more inclusive estimation of all capacitance vessels throughout the body, not just central vasculature. As such, both measures off er unique evidence and are best interpreted in relation to like measures.
Practical applications
The fi nding that arterial stiff ness decreased at the 45 km distance and then reverted back toward baseline levels with prolonged running, may indicate a role of exercise duration for aff ecting vascular compliance, even in the absence of extreme intensity, which is known to lead to acute stiff ening. At present, it is premature to suggest that athletes alter training or racing practices to protect vascular health, as the magnitude, duration and implications of possible changes are still unclear.
Conclusion
▼
Tracking the arterial stiff ness of ultra-marathon runners throughout prolonged exercise revealed a change toward more distensible arteries following 45 km of moderate intensity running. Although the intensity remained consistent, this eff ect was not maintained following an additional 30 km of running.
